Verdict could impact hundreds of additional
lawsuits filed
against Abbott and Enfamil formula maker
Reckitt Benckiser
ST.
LOUIS, July 26, 2024 /PRNewswire/ -- A
closely watched necrotizing enterocolitis (NEC) baby formula
bellwether trial culminated in a $495
million judgment Friday against Abbott Laboratories, a
verdict that could affect many other lawsuits awaiting litigation
in state and federal courts throughout the U.S.
A closely watched NEC baby formula trial
culminated in a $495 million judgment
against Abbott Laboratories.
The case in the St. Louis
trial, Gill v. Abbott Laboratories, No. 2322-CC01251, began
July 9 before Judge Michael Noble in the 22nd Judicial Circuit
Court of Missouri. The plaintiff brought the claim on
behalf of her minor child, who developed NEC after being given
Similac and/or Enfamil cow's milk-based products following her
premature birth. The infant was forced to undergo extensive surgery
and has continued to suffer long-term health consequences.
The jury awarded the Gill family $400
million in punitive damages and $95
million in compensatory damages.
The plaintiff and her child were represented by the law firms of
Stranch, Jennings & Garvey PLLC (SJ&G) and TorHoerman
Law.
"The jury followed the evidence and made the right decision,"
says Hon. John (Jack) Garvey,
founding member of SJ&G and co-lead counsel for the lawsuit. "I
consider it a great honor to have brought some level of justice to
the family."
The lawsuit asserted that, "despite scientific consensus that
defendants' cow's milk-based products present a dire threat to the
health and development of preterm infants, defendants have made no
changes to their products or the products' packaging, guidelines,
instructions, or warnings. Instead, defendants have continued to
sell their unreasonably dangerous products to unsuspecting parents
and healthcare providers, generating huge profits as a result."
The lawsuit also claimed the defendants breached their duty
through misrepresentations made to consumers, physicians and
medical staff in their advertising and promotional materials and
interactions, and that Abbott's acts, omissions and/or
representations showed a deliberate and flagrant disregard for the
safety of others.
"This is the sort of litigation that our firm takes pride in —
where you need to commit massive resources to take on the most
powerful bad actors," says J. Gerard
Stranch IV, founding and managing member of SJ&G.
In addition to Jack Garvey,
SJ&G's trial team included Founding Member Mike Stewart and
Member Janna Maples, along with associate attorneys Colleen Garvey, Ellen A.
Thomas and Caleb
Harbison.
Hundreds of lawsuits still pending allege that
cow's milk-based baby formula products can cause NEC, a
life-threatening illness that can affect premature infants. In
addition, the lawsuits claim that manufacturers of these products
failed to warn of the higher risk of NEC in infants who were given
their products versus infants who received breast milk or human
milk-derived formula.
Gill v. Abbott Laboratories marked the first NEC case brought
against Abbott and was the second trial alleging that cow's
milk-based baby formula given to premature infants can cause NEC.
In the earlier case, Watson vs. Mead Johnson, an Illinois jury awarded $60 million to a plaintiff whose child died from
NEC.
For additional information about SJ&G, visit
www.stranchlaw.com.
About Stranch, Jennings & Garvey, PLLC:
With practice experience dating back decades, Stranch, Jennings
& Garvey, PLLC has a longstanding history of prominence in
complex litigation. Our attorneys specialize in class action, mass
tort, ERISA trust funds, labor unions, bank fees, data breaches,
wage and hour disputes, worker adjustment and retraining
notification, product liability, personal injury and trucking
accidents. Known for their integrity, experience and dedication,
our attorneys are members of numerous state and national
associations, committees and boards.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/historic-st-louis-nec-baby-formula-trial-results-in-nearly-500-million-judgment-302208037.html
SOURCE Stranch, Jennings & Garvey